Physician

Deanna Nabors, MD

According to 2025 Medicare claims, Deanna Nabors, MD (NPI: 1619939204) practices internal medicine in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from De Soto, MS. This provider's primary affiliated billing organization is FAMILY MEDICAL CLINIC OF NORTH MS INC (NPI: 1134174154; TIN: 331019957) and primary practice location at 38672-9304. Nabors is affiliated with the Aledade 79 AL MSSP Enhanced (ACO ID: A4894) and Aledade 102 NC TN CHC MSSP Enhanced (ACO ID: A5002), participating under the MSSP model.

Nabors' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 344 traditional Medicare patients, billed 2,638 HCPCS/CPT codes, and received $90,439 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,205 prescription claims across 558 beneficiaries totaling $522,663 in drug costs, led by Jardiance (Empagliflozin). DME data shows 17 claims. Open Payments data shows 22 records totaling $352. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $173,926 to $90,439. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $581,078 and ending at $522,663. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $22,689 to $7,420.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	455	10,619	$173,926
2016	597	7,236	$111,619
2017	549	8,589	$222,941
2018	567	10,988	$289,076
2019	536	11,166	$288,174
2020	623	10,552	$266,156
2021	591	10,663	$284,056
2022	747	11,157	$353,383
2023	487	3,898	$106,866
2024	344	2,638	$90,439

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	383	9,826	$581,078
2016	501	8,373	$547,709
2017	598	6,314	$335,351
2018	497	8,059	$407,062
2019	512	8,352	$499,516
2020	505	8,544	$635,457
2021	525	8,635	$739,807
2022	572	9,141	$813,906
2023	663	6,327	$761,857
2024	558	4,205	$522,663

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	103	470	$15,342
2016	92	557	$18,582
2017	38	128	$4,308
2018	25	175	$6,392
2019	43	154	$2,556
2020	40	115	$1,390
2021	38	173	$33,921
2022	38	187	$10,774
2023	20	161	$9,880
2024	N/R	17	$4,806

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	171	250	$95
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	142	307	$48
80061	Blood test, lipids (cholesterol and triglycerides)	127	133	$13
80053	Blood test, comprehensive group of blood chemicals	135	142	$10
36415	Insertion of needle into vein for collection of blood sample	166	221	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	69	5,320	$101,548
Ozempic	Semaglutide	60	3,042	$97,207
Mounjaro	Tirzepatide	16	904	$32,130
Januvia	Sitagliptin Phosphate	24	1,680	$30,914
Eliquis	Apixaban	22	1,395	$26,120

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	17	$4,806

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$352	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deanna Nabors, MD?

Tedicare shows public-source Medicare data for Deanna Nabors, MD (NPI 1619939204), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deanna Nabors, MD have ACO affiliation data?

Deanna Nabors, MD is shown with ACO affiliation data for Aledade 79 AL MSSP Enhanced (MSSP, ACO ID A4894) and Aledade 102 NC TN CHC MSSP Enhanced (MSSP, ACO ID A5002).

What billing organization is linked to Deanna Nabors, MD?

Deanna Nabors, MD is linked to FAMILY MEDICAL CLINIC OF NORTH MS INC (billing NPI 1134174154) in the available physician profile data.

Does Deanna Nabors, MD have Open Payments data?

Deanna Nabors, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.